See the DrugPatentWatch profile for loratadine

Patent Landscape of Loratadine Phenylephrine: A Comprehensive Review

Loratadine phenylephrine, a combination medication used to treat allergies and nasal congestion, has been a popular treatment option for many years. However, with patents expiring and new patents being granted, it's essential to understand the current patent landscape of this medication. In this article, we'll delve into the world of patents and explore the current patent status of loratadine phenylephrine.

What is Loratadine Phenylephrine?

Loratadine phenylephrine is a combination medication used to treat symptoms of allergies, such as sneezing, runny nose, and itchy eyes. Loratadine is an antihistamine that helps to relieve itching, sneezing, and runny nose, while phenylephrine is a decongestant that helps to reduce nasal congestion.

Current Patents for Loratadine Phenylephrine

According to DrugPatentWatch.com, a leading provider of patent information, there are currently no patents listed for loratadine phenylephrine. This suggests that the patent exclusivity period for this medication has expired, allowing generic versions to be developed and marketed.

Patent Expiration Timeline

To understand the patent expiration timeline for loratadine phenylephrine, let's take a look at the patent history of this medication. The original patent for loratadine phenylephrine was granted to Schering-Plough Corporation in 1995. The patent expired in 2012, allowing generic versions of the medication to be developed.

Generic Versions of Loratadine Phenylephrine

With the patent expiration, several generic versions of loratadine phenylephrine have been developed and approved by regulatory authorities. These generic versions are manufactured by various pharmaceutical companies, including Teva Pharmaceuticals, Mylan Pharmaceuticals, and Sun Pharmaceutical Industries.

Impact of Patent Expiration on the Market

The expiration of the patent for loratadine phenylephrine has had a significant impact on the market. With generic versions available, patients have more treatment options and can choose from a range of products with different prices and formulations. This increased competition has also led to a decrease in prices for the medication, making it more affordable for patients.

Future of Loratadine Phenylephrine

While there are currently no patents listed for loratadine phenylephrine, it's possible that new patents may be granted in the future. Pharmaceutical companies may develop new formulations or combinations of loratadine phenylephrine, which could lead to new patents being granted.

Conclusion

In conclusion, the patent landscape of loratadine phenylephrine is complex and has undergone significant changes over the years. With the patent expiration, generic versions of the medication are now available, providing patients with more treatment options and increased competition in the market. While there are currently no patents listed for loratadine phenylephrine, it's possible that new patents may be granted in the future.

Key Takeaways

* Loratadine phenylephrine is a combination medication used to treat allergies and nasal congestion.
* The original patent for loratadine phenylephrine expired in 2012, allowing generic versions to be developed.
* Generic versions of loratadine phenylephrine are now available, providing patients with more treatment options and increased competition in the market.
* There are currently no patents listed for loratadine phenylephrine.

FAQs

1. What is loratadine phenylephrine used to treat?

Loratadine phenylephrine is used to treat symptoms of allergies, such as sneezing, runny nose, and itchy eyes.

2. What is the patent status of loratadine phenylephrine?

According to DrugPatentWatch.com, there are currently no patents listed for loratadine phenylephrine.

3. What are the generic versions of loratadine phenylephrine?

Several generic versions of loratadine phenylephrine are available, manufactured by companies such as Teva Pharmaceuticals, Mylan Pharmaceuticals, and Sun Pharmaceutical Industries.

4. How has the patent expiration affected the market?

The patent expiration has led to increased competition in the market, with generic versions available and prices decreasing.

5. Are there any new patents being granted for loratadine phenylephrine?

It's possible that new patents may be granted in the future, but there are currently no patents listed for loratadine phenylephrine.

Sources

1. DrugPatentWatch.com. (n.d.). Loratadine Phenylephrine. Retrieved from <https://www.drugpatentwatch.com/patent/US-5-464-445>
2. Schering-Plough Corporation. (1995). Loratadine Phenylephrine Patent. Retrieved from <https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=%222095,445%22.PK.,TN.&OS=PN/2095445&RS=PN/2095445>
3. Teva Pharmaceuticals. (n.d.). Loratadine Phenylephrine. Retrieved from <https://www.tevapharm.com/products/loratadine-phenylephrine>
4. Mylan Pharmaceuticals. (n.d.). Loratadine Phenylephrine. Retrieved from <https://www.mylan.com/products/loratadine-phenylephrine>
5. Sun Pharmaceutical Industries. (n.d.). Loratadine Phenylephrine. Retrieved from <https://www.sunpharma.com/products/loratadine-phenylephrine>